Detalles de la búsqueda
1.
SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-458667
2.
Probing Affinity, Avidity, Anti-Cooperativity, and Competition in Antibody and Receptor Binding to the SARS-CoV-2 Spike by Single Particle Mass Analyses
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-448939
3.
An alternative binding mode of IGHV3-53 antibodies to the SARS-CoV-2 receptor binding domain
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-222232
4.
Antibody responses to SARS-CoV-2 mRNA vaccines are detectable in saliva
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-434841
5.
Site-specific steric control of SARS-CoV-2 spike glycosylation
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-433764
6.
Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-233536
7.
Breastmilk; a source of SARS-CoV-2 specific IgA antibodies
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20176743
8.
Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21256092
9.
Afucosylated immunoglobulin G responses are a hallmark of enveloped virus infections and show an exacerbated phenotype in COVID-19
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-099507
10.
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-365726
Resultados
1 -
10
de 10
1
Próxima >
>>